|
1
|
Ren YL, Nong L, Zhang S, Zhao J, Zhang XM
and Li T: Analysis of 142 Northern Chinese patients with peripheral
T/NK-Cell lymphomas: Subtype distribution, clinicopathologic
features, and prognosis. Am J Clin Pathol. 138:435–447. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan JK, Quintanilla-Martinez L, Ferry JA,
et al: Extrannodal NK/T-cell lymphoma, nasal type. Swerdlow SH,
Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J and
Vardiman JW: WHO classification of tumours of haematopoietic and
lymphoid tissues Lyon, France: IARC Press; pp. 285–288. 2008
|
|
3
|
Chan JKC, Quintanilla-Martinez L and Ferry
JA: Extrannodal NK/T-cell lymphoma, nasal type. Swerdlow SH, Campo
E, Harris NL, Jaffe ES, Pileri SA, Stein H and Thiele J: WHO
classification of tumours of haematopoietic and lymphoid tissues,
revised. 4th. IARC Press; Lyon: pp. 368–371. 2017
|
|
4
|
Ko YH, Ree HJ, Kim WS, Choi WH, Moon WS
and Kim SW: Clinicopathologic and genotypic study of extranodal
nasal-type natural killer/t-cell lymphoma and natural killer
precursor lymphoma among Koreans. Cancer. 89:2106–2116. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bakos A, Szomor Á, Schneider T, Miltényi
Z, Marton I, Borbényi Z, Pammer J, Krenács L, Bagdi E and Piukovics
K: Incidence and treatment of extranodal natural killer/T-cell
lymphoma nasal type. Hungarian experiences. Orv Hetil.
158:1635–1641. 2017.(In Hungarian). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jones JF, Shurin S, Abramowsky C, Tubbs
RR, Sciotto CG, Wahl R, Sands J, Gottman D, Katz BZ and Sklar J:
T-cell lymphomas containing Epstein-Barr viral DNA in patients with
chronic Epstein-Barr virus infections. N Engl J Med. 318:733–741.
1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harabuchi Y, Yamanaka N, Kataura A, Imai
S, Kinoshita T, Mizuno F and Osato T: Epstein-Barr virus in nasal
T-cell lymphomas in patients with lethal midline granuloma. Lancet.
335:128–130. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ho FC, Srivastava G, Loke SL, Fu KH, Leung
BP, Liang R and Choy D: Presence of Epstein-Barr virus DNA in nasal
lymphomas of B and ‘T’ cell type. Hemafol Oncol. 8:271–281. 1990.
View Article : Google Scholar
|
|
9
|
Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori
S, Feller AC and Ho FC: Report of the workshop on nasal and related
extranodal angiocentric T/natural killer cell lymphomas.
Definitions, differential diagnosis, and epidemiology. Am J Surg
Pathol. 20:103–111. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chan JK, Jafe ES and Ralfkiaer E:
Extranodal NK/T cell lymphoma, nasal type. Jafe ES, Harris NL,
Stein H, et al: World Health Organization classification of
tumours: Pathology and genetics of tumours of haematopoietic and
lymphoid tissues. IARC Press; Lyon, France: pp. 204–207. 2001
|
|
11
|
George LC, Rowe M and Fox CP: Epstein-Barr
virus and the pathogenesis of T and NK lymphoma: A mystery
unsolved. Curr Hematol Malig Rep. 7:276–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakamura S, Katoh E, Koshikawa T, Yatabe
Y, Nagasaka T, Ishida H, Tokoro Y, Koike K, Kagami Y, Ogura M, et
al: Clinicopathologic study of nasal T/NK-cell lymphoma among the
Japanese. Pathology Int. 47:38–53. 1997. View Article : Google Scholar
|
|
13
|
Hasserjian RP and Harris NL: NK-cell
lymphomas and leukemias: A spectrum of tumors with variable
manifestations and immunophenotype. Am J Clin Pathol. 127:860–868.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lister TA, Crowther D, Sutcliffe SB,
Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA and
Tubiana M: Report of a committee convened to discuss the evaluation
and staging of patients with Hodgkin's disease: Cotswolds meeting.
J Clin Oncol. 7:1630–1636. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang S, Li T, Zhang B, Nong L and Aozasa
K: Transcription factors engaged in development of NK cells are
commonly expressed in nasal NK/T-cell lymphomas. Hum Pathol.
42:1319–1328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang L, Zhang Z, Wang Y, Nong L, Zheng Y,
Qu L, Zhang B and Li T: The genetic deletion of 6q21 and PRDM1 and
clinical implications in extranodal NK/T cell lymphoma, nasal type.
Biomed Res Int. 2015:4354232015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Van Dongen JJ, Langerak AW, Brüggemann M,
Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E,
García-Sanz R, et al: Design and standardization of PCR primers and
protocols for detection of clonal immunoglobulin and T-cell
receptor gene recombinations in suspect lymphoproliferations:
Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia.
17:2257–2317. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujiwara S, Kimura H, Imadome K, Arai A,
Kodama E, Morio T, Shimizu N and Wakiguchi H: Current research on
chronic active Epstein-Barr virus infection in Japan. Pediatr Int.
56:159–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Delecluse HJ, Feederle R, O'Sullivan B and
Taniere P: Epstein-Barr virus-associated tumours: An update for the
attention of the working pathologist. J Clin Pathol. 60:1358–1364.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gru AA, Haverkos BH, Freud AG, Hastings J,
Nowacki NB, Barrionuevo C, Vigil CE, Rochford R, Natkunam Y,
Baiocchi RA and Porcu P: The Epstein-Barr virus (EBV) in T cell and
NK cell lymphomas: Time for a reassessment. Curr Hematol Malig Rep.
10:456–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li T, Hongyo T, Syaifudin M, Nomura T,
Dong Z, Shingu N, Kojya S, Nakatsuka S and Aozasa K: Mutations of
the p53 gene in nasal NK/T-cell lymphoma. Lab Invest. 80:493–499.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Teo WL and Tan SY: Loss of Epstein-Barr
virus-encoded RNA expression in cutaneous dissemination of natural
killer/T-cell lymphoma. J Clin Oncol. 29:e342–e343. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tsuyama N, Asaka R, Dobashi A, Baba S,
Mishima Y, Ueda K, Oguchi M, Tsuji H, Hatake K and Takeuchi K:
Epstein-Barr virus-negative extranodal ‘true’ natural killer-cell
lymphoma harbouring a KDM6A mutation. Hematol Oncol. 36:328–335.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bouchekioua A, Scourzic L, de Wever O,
Zhang Y, Cervera P, Aline-Fardin A, Mercher T, Gaulard P, Nyga R,
Jeziorowska D, et al: JAK3 deregulation by activating mutations
confers invasive growth advantage in extranodal nasal-type natural
killer cell lymphoma. Leukemia. 28:338–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mundo L, Ambrosio MR, Picciolini M, Lo
Bello G, Gazaneo S, Del Porro L, Lazzi S, Navari M, Onyango N,
Granai M, et al: Unveiling another missing piece in EBV-driven
lymphomagenesis: EBV-encoded MicroRNAs expression in EBER-negative
burkitt lymphoma cases. Front Microbiol. 8:2292017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ko YH, Cho EY, Kim JE, Lee SS, Huh JR,
Chang HK, Yang WI, Kim CW, Kim SW and Ree HJ: NK and NK-like T-cell
lymphoma in extranasal sites: A comparative clinicopathological
study according to site and EBV status. Histopathology. 44:480–489.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nicolae A, Ganapathi KA, Pham TH, Xi L,
Torres-Cabala CA, Nanaji NM, Zha HD, Fan Z, Irwin S, Pittaluga S,
et al: EBV-negative aggressive NK-cell leukemia/lymphoma: Clinical,
pathologic, and genetic features. Am J Surg Pathol. 41:67–74. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ko YH, Park S, Kim K, Kim SJ and Kim WS:
Aggressive natural killer cell leukemia: Is Epstein-Barr virus
negativity an indicator of a favorable prognosis? Acta Haematol.
120:199–206. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kanno H, Watabe D, Shimizu N and Sawai T:
Adhesion of Epstein-Barr virus-positive natural killer cell lines
to cultured endothelial cells stimulated with inflammatory
cytokines. Clin Exp Immunol. 151:519–527. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Takeshita M, Yamamoto M, Kikuchi M, Kimura
N, Nakayama J, Uike N, Daimaru H, Sawada H and Okamura T:
Angiodestruction and tissue necrosis of skin-involving CD56+
NK/T-cell lymphoma are influenced by expression of cell adhesion
molecules and cytotoxic granule and apoptosis-related proteins. Am
J Clin Pathol. 113:201–211. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin TC, Liu TY, Hsu SM and Lin CW:
Epstein-Barr virus-encoded miR-BART20-5p inhibits T-bet translation
with secondary suppression of p53 in invasive nasal NK/T-cell
lymphoma. Am J Pathol. 182:1865–1875. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strengell M, Matikainen S, Sirén J,
Lehtonen A, Foster D, Julkunen I and Sareneva T: IL-21 in synergy
with IL-15 or IL-18 enhances IFN-gamma production in human NK and T
cells. Immunol. 170:5464–5469. 2003. View Article : Google Scholar
|
|
33
|
Agnello D, Lankford CS, Bream J, Morinobu
A, Gadina M, O'Shea JJ and Frucht DM: Cytokines and transcription
factors that regulate T helper cell differentiation: New players
and new insights. J Clin Immunol. 23:147–161. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Queen KJ, Shi M, Zhang F, Cvek U and Scott
RS: Epstein-Barr virus-induced epigenetic alterations following
transient infection. Int J Cancer. 132:2076–2086. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Birdwell CE, Queen KJ, Kilgore PC,
Rollyson P, Trutschl M, Cvek U and Scott RS: Genome-wide DNA
methylation as an epigenetic consequence of Epstein-Barr virus
infection of immortalized keratinocytes. J Virol. 88:11442–11458.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Martin AR, Chan WC, Perry DA, Greiner TC
and Weisenburger DD: Aggressive natural killer cell lymphoma of the
small intestine. Mod Pathol. 8:467–472. 1995.PubMed/NCBI
|
|
37
|
Iqbal J, Kucuk C, Deleeuw RJ, Srivastava
G, Tam W, Geng H, Klinkebiel D, Christman JK, Patel K, Cao K, et
al: Genomic analyses reveal global functional alterations that
promote tumor growth and novel tumor suppressor genes in natural
killer-cell malignancies. Leukemia. 23:1139–1151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao J, Behdad A, Ji P, Wolniak KL,
Frankfurt O and Chen YH: EBV-negative aggressive NK-cell
leukemia/lymphoma: A clinical and pathological study from a single
institution. Mod Pathol. 30:1100–1115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Z, Liang L, Li D, Nong L, Liu J, Qu
L, Zheng Y, Zhang B and Li T: Hypermethylation of PRDM1/Blimp-1
promoter in extranodal NK/T-cell lymphoma, nasal type: An evidence
of predominant role in its downregulation. Hematol Oncol.
35:645–654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
de Mel S, Hue SS, Jeyasekharan AD, Chng WJ
and Ng SB: Molecular pathogenic pathways in extranodal NK/T cell
lymphoma. J Hematol Oncol. 12:332019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Quintanilla-Martinez L, Kremer M, Keller
G, Nathrath M, Gamboa-Dominguez A, Meneses A, Luna-Contreral L,
Cabras A, Hoefler H, Mohar A and Fend F: p53 Mutations in nasal
natural killer/T-cell lymphoma from Mexico: Association with large
cell morphology and advanced disease. Am J Pathol. 159:2095–2105.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Northrup D, Yagi R, Cui K, Proctor WR,
Wang C, Placek K, Pohl LR, Wang R, Ge K, Zhu J and Zhao K: Histone
demethylases UTX and JMJD3 are required for NKT cell development in
mice. Cell Biosci. 7:252017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Asif S, Begemann M, Bennett J, Fatima R,
Masood A and Raza S: Pembrolizumab in newly diagnosed EBV-negative
extranodal natural killer/T-cell lymphoma: A case report. Mol Clin
Oncol. 10:397–400. 2019.PubMed/NCBI
|
|
44
|
Harabuchi Y, Kataura A and Imai K:
Circulating intercellular adhesion molecule-1 and its cellular
expression in head and neck non-Hodgkin's lymphomas, including
lethal midline granuloma. Ann Otol Rhinol Laryngol. 105:634–642.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cuadra-Garcia I, Proulx GM, Wu CL, Wang
CC, Pilch BZ, Harris NL and Ferry JA: Sinonasal lymphoma: A
clinicopathologic analysis of 58 cases from the massachusetts
general hospital. Am J Surg Pathol. 23:1356–1369. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Quintanilla-Martinez L, Franklin JL,
Guerrero I, Krenacs L, Naresh KN, Rama-Rao C, Bhatia K, Raffeld M
and Magrath IT: Histological and immunophenotypic profile of nasal
NK/T cell lymphomas from Peru: High prevalence of p53
overexpression. Hum Pathol. 30:849–855. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jung CK, Lee KY, Kim Y, Han K, Shim SI,
Kim BK and Kang CS: Epstein-Barr virus infection, drug resistance
and prognosis in Korean T- and NK-cell lymphomas. Pathol Int.
51:355–363. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ohshima K, Liu Q, Koga T, Suzumiya J and
Kikuchi M: Classification of cell lineage and anatomical site, and
prognosis of extranodal T-cell lymphoma-natural killer cell,
cytotoxic T lymphocyte, and non-NK/CTL types. Virchows Arch.
440:425–435. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kim JE, Kim YA, Jeon YK, Park SS, Heo DS
and Kim CW: Comparative analysis of NK/T-cell lymphoma and
peripheral T-cell lymphoma in Korea: Clinicopathological
correlations and analysis of EBV strain type and 30-bp deletion
variant LMP1. Pathol Int. 53:735–743. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ng SB, Lai KW, Murugaya S, Lee KM, Loong
SL, Fook-Chong S, Tao M and Sng I: Nasal-type extranodal natural
killer/T-cell lymphomas: A clinicopathologic and genotypic study of
42 cases in Singapore. Mod Pathol. 17:1097–1107. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Miyazato H, Nakatsuka S, Dong Z, Takakuwa
T, Oka K, Hanamoto H, Tatsumi Y, Kanamaru A and Aozasa K; Osaka
Lymphoma Study Group, : NK-cell related neoplasms in Osaka, Japan.
Am J Hematol. 76:230–235. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tai YC, Kim LH and Peh SC: High frequency
of EBV association and 30-bp deletion in the LMP-1 gene in CD56
lymphomas of the upper aerodigestive tract. Pathol Int. 54:158–166.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Cabrera ME, Eizuru Y, Itoh T, Koriyama C,
Tashiro Y, Ding S, Rey S, Akiba S and Corvalan A: Nasal natural
killer/T-cell lymphoma and its association with type ‘i’/Xhol loss
strain Epstein-Barr virus in Chile. J Clin Pathol. 60:656–660.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Matsuda M, Iwanaga T, Hashimoto S, Uesugi
T and Itagaki N: Primary Epstein-Barr virus-negative nasal-type
natural killer/T cell lymphoma of the testis. Leuk Res.
33:e119–e120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kim HS, Lee HW, Kim WS and Ko YH: Systemic
Epstein-Barr virus-negative mature natural killer-cell lymphoma
with cutaneous and visceral involvement. APMIS. 123:990–992. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tian C, Wang Y, Zhu L, Yu Y and Zhang Y:
Primary bone natural killer/T cell lymphoma, nasal type without EBV
infection: A case report. Int J Clin Exp Pathol. 8:14836–14839.
2015.PubMed/NCBI
|
|
57
|
Zeng LS, Huang WT, Qiu T, Shan L, Guo L,
Ying JM, Lyu N and Feng XL: Correlation between the
clinicopathological features and prognosis in patients with
extranodal natural killer/T cell lymphoma. Chronic Dis Transl Med.
3:252–259. 2017.PubMed/NCBI
|
